Genenta Science S.p.A GNTA
NASDAQ GNTA
$1.26 +0.07 (+5.88%)
At close: Aug 21, 2026 · 4:00 PM EDT

Genenta Science S.p.A (GNTA) Shares Outstanding (2021 - 2025)

Genenta Science S.p.A (GNTA) posted Shares Outstanding (Entity) of $18.8 million for Q2 2025, up 2.71% sequentially from $18.3 million in Q4 2024, and up 2.8% YoY from $18.3 million in Q2 2024.

Genenta Science S.p.A (GNTA) Shares Outstanding (2021 - 2025) Analysis & Trends

Genenta Science S.p.A has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $18.8 million in Q2 2025.

  • Quarterly Shares Outstanding (Entity) rose 2.8% year-over-year to $18.8 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was $18.8 million (up 2.8% YoY) and the FY2024 annual result came in at $18.3 million, changed 0.31% from the prior year.
  • Shares Outstanding (Entity) rose to $18.8 million in Q2 2025 per GNTA's latest filing, from $18.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $18.8 million in Q2 2025 and troughed at $15.1 million in Q4 2021.
  • A 5-year average of $17.9 million and a median of $18.2 million in 2022 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2021 and 2022: Shares Outstanding (Entity) fell 17.2% in 2021, then rose 20.77% in 2022.
  • Over 5 years, Shares Outstanding (Entity) stood at $15.1 million in 2021, then increased by 20.77% to $18.2 million in 2022, then gained by 0.0% to $18.2 million in 2023, then gained by 0.31% to $18.3 million in 2024, then rose by 2.71% to $18.8 million in 2025.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $18.8 million, $18.3 million, and $18.3 million for Q2 2025, Q4 2024, and Q2 2024 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 62.19 Mn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 445.06 Mn
10 Genenta Science S.p.A 25.03 Mn -34.07 Mn - 19.71 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 19.71 Mn
Jun 30, 2025 18.77 Mn
Dec 31, 2024 18.27 Mn
Jun 30, 2024 18.26 Mn
Dec 31, 2023 18.22 Mn
Jun 30, 2023 18.22 Mn
Dec 31, 2022 18.22 Mn
Jun 30, 2022 18.22 Mn
Dec 31, 2021 15.08 Mn